In commemorating its 60th Anniversary, DIA has illuminated the path, fostering a global platform for unbiased idea exchange, propelling scientific and medical progress. The DIA 2024 Global Annual Meeting, buoyed by thousands of attendees, embarks on a voyage to tackle both global and local life sciences challenges. It unites industry, regulators, academics, and patients in this collective mission.

Read on diaglobal.org

The Health Evolution Summit is a select gathering of CEOs from health system, health plan, and life science firms, along with key policymakers. Committed to healthcare transformation, we convene for three days in Laguna. Here, we engage in candid debates, foster relationships, and spark creative solutions vital to the industry's future.

Read on healthevolution.com

Rotterdam hosts the 11th Innovation for Health conference on March 28, 2024. Under the theme "Breaking Boundaries for a Sustainable Future in Healthcare," the event unites Health & Life Sciences leaders. With top-tier speakers, impactful innovations, and networking opportunities, the conference brings together over 800 experts, fostering collaborations and shaping healthcare's future.

Read on hyphenprojects.nI

Bio-IT World is the world’s premier event for technologies and analytic approaches that solve problems, accelerate science, and drive the future of precision medicine. For over 20 years, the Bio-IT World Conference & Expo has been the world’s premier event showcasing the technologies and analytic approaches that solve problems, accelerate science, and drive the future of precision medicine. Bio-IT World has united a community of leading life sciences, pharmaceutical, clinical, healthcare, informatics, and technology experts in the fields of biomedical research, drug discovery & development, and healthcare from around the world. Since 2002, the Bio-IT World Conference & Expo has taken place annually in Boston and on 18-19 October, 2022, the event will host conversations that connect the people, ideas, and opportunities across Europe. Join your colleagues for updates from inspiring keynotes, more than 60 presentations across five tracks, and 2 days of interactive discussion and networking.

Read on bio-itworldeurope.com

International Conference on Microbial Technology and Ecology (ICMTE - 23), taking place in Bali, Indonesia on 15th September 2023 . Hosted by one of the most trusted organizations, SAIRAP, the conference provides a premier global platform for exchanging ideas and insights on the latest developments across various fields. Our goal is to offer a competitive venue for industry professionals and academic researchers to showcase and discuss cutting-edge advancements in their respective fields. The primary objective of this conference is to provide attendees with a unique opportunity to share their experiences, knowledge, and ideas on a global stage.  The conference also offers an excellent opportunity for delegates to establish business and research relationships and engage in high-level business and scientific discussions. This conference is sure to provide significant contributions to your professional growth and knowledge base. The theme and objective of the conference is centered around addressing the key challenges faced by various industries, including engineering, medicine, social science, applied science, management, and others. The aim is to bring together organizations and professionals from these fields to identify bottlenecks and collaborate on finding solutions.

Read on: sairap.org

The 2023 IIER International Conference on Recent Advances in Medical Science (ICRAMS) is set for August 24-25 in San Jose, United States. Sponsored by the International Institute of Engineers and Researchers (IIER), it aims to be a premier global platform for introducing innovative advancements in Medical Science. With a history since 2014, ICRAMS facilitates communication among researchers and practitioners, promoting progress in Medical Science techniques. The event annually gathers prominent scientists, engineers, and researchers worldwide to share technological breakthroughs and findings.

Read on theiier.org

Global Biotechnology Summit organizing committee with great honor extending you a warm invitation to attend the Global Biotechnology Summit which is slated to held in 16th August to 17th August 2023 in San Miguel de Tucuman, ARGENTINA. The Conference will offer a wide platform to share vital and recent innovations in the arena Global Biotechnology Summit. It also has a wonderful space for both scientific presentations like oral, poster and commercial exhibition. GBS have an exciting program that will allow the participants to reflect upon and celebrate the past accomplishments, renew friendships, extended networking opportunities, foster communication between speakers and delegates and jointly unveil current and future research directions. We hope that you will have a useful and fun filled time in San Miguel de Tucuman, ARGENTINA at this special GBS. We look forward to welcoming you all for what promises to be an outstanding event.

Read on scienceleagues.com

Join us for our 3rd Annual Pharma/Life Science Virtual Summit as our carefully curated experts dive into everything from exploring unconventional methods for mental health treatment to discovering the full potential of biosimilars and biologics. This summit will also cover how to achieve supply chain sustainability in the pharmaceutical industry, closing the equity gap around digital health solutions and maximizing minimally invasive surgeries to create better patient outcomes.

Read on xtelligentvirtualsummits.brighttalk.com

Welcome to International Conference on Biology and Life Science (ICBLS - 23), an exciting event that strives to bring together all stakeholders in the discipline of Biology and Life Science to promote authentic and accelerated scientific research progress. At our conference, participants, keynote speakers, presenters, volunteers, and others will gain access to best-in-class resources, infrastructure, and opportunities to help them achieve their professional objectives, no matter how diverse and varied they may be. 

At (ICBLS - 23), our participants will gather together to achieve collective priorities, including the dissemination of knowledge generated through international research studies and strengthening the global Biology and Life Science community. Each session has been meticulously designed to help participants fulfill these goals, as well as their personal objectives.

Read on sciencenet.co/event/index

International Conference on Applied Informatics for Health, Medical and Life Sciences aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Applied Informatics for Health, Medical and Life Sciences. It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Applied Informatics for Health, Medical and Life Sciences.

Read on waset.org

Life science Congress 2023 which is going to be held during April 19-20, 2023 in Rome, Italy.

Lifescience congress 2023  will create platform for health professionals, researchers, scientists, academicians, clinicians and business professionals across the globe to present their latest research, new technologies their knowledge through mutual interaction and exchange of ideas in different destinations around the world. Healthcare administrators focus on managing staff needs, and healthcare managers focus on the broader business aspects of a medical facility.

Read on lifescience.annualcongress.com

At Innovation for Health 2023, you get to share insights, catch up on the latest trends, establish new or build upon valuable connections and collaborations, and much more. With our energizing programme, we bring top-notch speakers to the stage, display high-impact innovations, highlight best practices, and demonstrate inspiring developments in healthcare. Inspiring, interacting, and networking are at the heart of the conference. Moreover, the conference brings over 900 innovators, entrepreneurs, thought leaders, and other key players from Health & Life Sciences together to shape the future of healthcare together. The theme for this next edition will be Digital Transformation in Healthcare.

Read on hyphenprojects.nl

Interest in life sciences has experienced unprecedented growth, especially in biopharmaceuticals, the food industry and biomedical technology. Join us virtually to hear experts discuss topics like the evolution of clinical trials and biotech as well as the future of this industry.

Read on view.ceros.com

The blood-brain barrier is a set of specialized and highly selective cellular barriers that protects the central nervous system (CNS). While necessary under normal physiology, the blood-brain barrier prevents entry of many neurotherapeutics into the brain and biologic therapies such as antibodies and gene therapies are essentially excluded from the CNS. SRI International has developed an unbiased screening platform to identify peptides that mediate delivery throughout the CNS without disruption of the blood-brain barrier or destruction of biological cargo. This approach, named DiaCyt (Dia: Through and Cyt: Cell), utilizes high diversity phage-displayed peptide libraries to peptides that transport cargos across a cellular barrier.

Read on xtalks.com

Digital health technologies have the potential to revolutionize medicine, shifting the focus from reactive treatment to proactive prevention of acute illness. Although many of these technologies have existed for up to 30 years, adoption has been slow. The primary reason is there are few accepted digital biomarkers that indicate whether a person is getting better or worse — let alone identify when an intervention is recommended.

Read on xtalks.dryfta.com

Randomization and trial supply management (RTSM) and electronic data capture (EDC) technologies and systems are essential to managing clinical trials. As clinical trials become increasingly complex, biostatisticians become even more essential, providing the needed insight to understand protocol-specific randomization nuances and make optimal randomization decisions to improve trial outcomes. In this case study-focused webinar, the featured speakers will highlight how biostatistics is crucial at multiple stages of clinical trials such as study design, randomization implementation, rerandomization needs, randomization and drug supply checks, unblinding and final analysis.

Read on xtalks.dryfta.com

N-Nitrosamine impurity findings in marketed formulations of rifampin have disrupted drug development. As a strong cytochrome P450 3A4 (CYP3A4) inducer, rifampin was regularly co-administered with investigational products during pharmacokinetic drug-drug interaction studies. However, due to recent impurity issues, its application in these studies has been suspended in both the US and EU. This webinar will examine the root cause of rifampin impurity and describe the industry and regulatory response to this issue. In addition, the featured speakers will address alternative approaches and CYP3A inducers to encourage the continuation of drug-drug interaction studies and drug development.

N-Nitrosamines are a class of chemicals recognized as a “cohort of concern” due to their mutagenic and carcinogenic potential. Typically, levels above an acceptable intake limit may lead to a probable or possible risk of cancer in humans. Rifampin capsules were found to contain 1-methyl-4-nitrosopiperazine (MNP) above the acceptable intake limit of 0.16 ppm. However, it’s important to note that nitrosamines are not limited to drug products, and low levels can be found in drinking water, processed meats and tobacco exposure. Therefore, in theory, a diet low in nitrosamines could offset any potential exposure during rifampin drug-drug interaction studies.

Read on xtalks.com

How do you retain patients in a complex trial? For clinical research professionals, testing medications and procedures on patient populations who feel unwell and have mobility or logistical challenges can be taxing, physically, mentally and emotionally for patients and their families - disruptive to their everyday lives and to the everyday lives of their families. For many clinical trialists, patient retention and engagement, especially in a complex trial, are challenges that keep them up at night, worrying that valuable patients will not complete the trial. A DCT is proven to improve patient retention, but if it’s a method of conducting research that the trialist hasn’t experienced before, the benefit, value and possibilities when building decentralized trial visits into a protocol, might not be fully realized. There are many procedures that can be completed in the home, and a significant number of those are far more complex than anticipated. From double blinded healthcare professionals delivering IMP, to timed pharmacokinetic blood draws and digitally linked visits, there are so many complex visit types that can be delivered in a DCT.

Read on xtalks.com

The synthesis of long helical oligoamide foldamers composed of more than 20 aromatic monomers of 8-amino-2-quinoline carboxylic acid can now be routinely achieved by using an in lab-developed solid-phase foldamer synthesis (SPFS) methodology that relies on acid chloride activation. aThe automation of the SPFS conditions is revolutionizing the production of high molecular weight aromatic oligoamides with very good yield and purity and faster production compared to the manual approach. That constitutes a critical milestone in the field of aromatic foldamer chemistry with many concrete applications such as the modulation of protein-protein interactions in competitive research programs.

Read on xtalks.com

Advanced therapy medicinal products or ATMPs, are among the fastest growing areas of biotherapeutics, encompassing gene therapies, viral therapies, vaccines and cell therapies. The control strategies are very different from more traditional biologics, with quantitation of potency posing one of the greatest challenges. In this webinar, representative case studies will demonstrate considerations in the conception, development and validation of potency assays - mostly cell-based - for representative ATMPs. The use of different analytical technologies and complex assay schema will be provided along with consideration of timing, phase-appropriate validation (qualification) considerations and assay lifecycle guidance as the product moves through the clinical development phases. Topics for discussion will include data and statistical considerations and how data may be processed to extract relevant insights and monitor attributes such as relative potency. The implications of global regulatory guidance and precedence will also be discussed.

Read on xtalks.com

In today’s digital world, data is king, and the future is in robust systems and processes that ensure data integrity and value. Within the clinical trial industry, data is collected in many formats, and it must be filtered and managed to be useful. Controlling how it is stored, accessed and ultimately used is all part of assuring data reliability and protecting the safety of patients and the quality of the drugs created. In this webinar, the featured speakers will talk all things data - how it’s relevance and accessibility has flourished, how it’s shaping the clinical trial industry and the expected growth of data strategy as technologies and the roles in data management evolve.

Read on xtalks.com

As the radiopharmaceutical research and development landscape continues to advance, so do the complexities and challenges associated with clinical trials. Conducting radiopharmaceutical trials presents a unique set of obstacles, such as the challenge of capturing unique radiation induced toxicities in the context of enrolled patients’ overall radiation exposure. This requires an understanding of enrolled patients’ cumulative radiation exposure from previous radiation treatments and current studies. For clinical radiopharmaceutical studies, the broader team must understand the background of radiation dosimetry, radiation toxicity, normal organ dose constraints and how to capture these metrics within clinical trial data management. In this webinar, Medpace medical, operational, regulatory and core lab experts will explore considerations for radiation toxicity and analyze previous radiopharmaceutical case studies and draw on their 30+ years of integrated, global experience to examine strategies to successfully operationalize complex radiopharmaceutical trials and increase the probability of clinical and regulatory success.

Read on xtalks.com

The Life Sciences Strategy Summit on IP & Exclusivity will be taking place on 11-12th October to provide the latest legal information and challenges for pharmaceutical, biotech & medical device companies. By attending this event you will gain comprehensive answers to the fundamental strategic questions in the Life Science IP industry. Join leading speakers from across the industry from companies including: Sanofi, Fresenius Kabi, Chiesi Pharmaceuticals, Stada, Amgen and many more. Attend this event to participate in face-to-face discussions with leading members of the pharma, biotech and medical device industries and understand the latest strategic questions surrounding litigation, prosecution & exclusivity. 

Read on lsstrategysummit.com

The Fierce Leaders in Life Sciences Forum brings together forward-thinking minds from today’s life sciences industry and features insights from C-suite and executive leadership on the end-to-end drug development process, highlighting innovative approaches in today’s evolving healthcare landscape to conducting:

• R&D and translational science
• Clinical development
• Product commercialization

We are excited to announce the call for speakers for the Fierce Leaders in Life Sciences Forum. Share practical insights with the life sciences community on key decision-making that has helped position your organization as a leader in today's market, and highlight innovative approaches in today’s evolving healthcare landscape.

The founders of DxPx are all startup entrepreneurs and former industry executives who had the idea for this conference after having attended numerous partnering events where the vast majority of participants and investors were focused on pharma, biotech and drug screening opportunities.

With the gaining importance of diagnostics, digital health, precision medicine and life science tools, there‘s a need for a dedicated platform to bring together the relevant stakeholders and further drive our industries. Together with the support of our sponsors DxPx is hosted as an annual international partnering conference to facilitate licensing, financing, co-development and M&A opportunities and celebrates great success and fast growth.

Read on dxpx-conference.com

Join the community of 1,900 life sciences, pharmaceutical, clinical, healthcare, and IT professional attendees from 30+ countries come together at the 2021 Bio-IT World Conference & Expo.

Read on bio-itworldexpo.com

International Conference on Life Sciences and Healthcare aim to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Life Sciences and Healthcare. It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Life Sciences and Healthcare.